“New Therapies in Sickle Cell Disease: What Does that Mean for Us?” |
05/13/2019 - 12:00pm to 1:00pm |
“Modulating the Gut Microbiota: Strategies to Enhance the Efficacy of PD-1 Based Immunotherapy” and “When pH-Negative MPNs Start Blasting Off” |
06/24/2019 - 12:00pm to 1:00pm |
“Medical Oncology Private Practice 2019: View from the Trench” |
03/11/2019 - 12:00pm to 1:00pm |
“Linking Longevity Regulators and Stem Cells of the Immune System” |
06/10/2019 - 12:00pm to 1:00pm |
“Investigating Quality of Life and Mental Health Outcomes in Older Adults with Sickle cell Disease” and “Genomic Drivers of Immunogenicity and Immune Escape Mechanisms in DLBCL” |
10/01/2018 - 12:00pm to 1:00pm |
“Interstitial-Targeted Treatment of Cerebral Metastasis” |
08/06/2018 - 12:00pm to 1:00pm |
“Integration of Palliative Care for Patients with Hematologic Malignancies” |
02/04/2019 - 12:00pm to 1:00pm |
“Incorporating the Transcriptome to Improve Population-Specific Understanding and Prognosis in Breast Cancer Patients” |
09/24/2018 - 12:00pm to 1:00pm |
“Incidental Germline Findings in Next-Generation Sequencing: Incidence and Management Approaches” and “Management of Chronic Myeloid Leukemia in Pregnancy” |
07/30/2018 - 12:00pm to 1:00pm |
“Immunotherapy: Changing the Treatment Paradigm in Advanced Urothelial Carcinoma” and “Tumor Boards: History, Purpose and Evidence-Based?” |
01/28/2019 - 12:00pm to 1:00pm |